Skip to main content
. 2018 Apr 27;22(7):3464–3474. doi: 10.1111/jcmm.13624

Figure 1.

Figure 1

Identification of 2‐(methoxymethyl)pyrimido[1,2‐a]benzimidazol‐4‐ol, GMP‐1 as competitive inhibitor of Tom70‐Hsp90 interactions. A, Chemical structure of GMP‐1. B, Dot‐blot assay of interactions between human Tom70 protein and Hsp90 peptide conjugated to HRP (C90‐HRP) in the presence of DMSO and 100 μmol/L of GMP‐1. C, Dose‐dependent inhibition of Tom70‐ C90‐HRP interactions by GMP‐1. IC 50 was calculated as a mean value of 3 independent experiments